183 related articles for article (PubMed ID: 23300866)
21. The Risk of TB in Patients With Type 2 Diabetes Initiating Metformin vs Sulfonylurea Treatment.
Pan SW; Yen YF; Kou YR; Chuang PH; Su VY; Feng JY; Chan YJ; Su WJ
Chest; 2018 Jun; 153(6):1347-1357. PubMed ID: 29253553
[TBL] [Abstract][Full Text] [Related]
22. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
[TBL] [Abstract][Full Text] [Related]
23. Incidence of idiopathic cardiomyopathy in patients with type 2 diabetes in Taiwan: age, sex, and urbanization status-stratified analysis.
Chen HF; Chang YH; Lo HJ; Isfandiari MA; Martini S; Hou WH; Li CY
Cardiovasc Diabetol; 2020 Oct; 19(1):177. PubMed ID: 33054769
[TBL] [Abstract][Full Text] [Related]
24. Antihyperglycemic drugs use and new-onset atrial fibrillation in elderly patients.
Chen HY; Yang FY; Jong GP; Liou YS
Eur J Clin Invest; 2017 May; 47(5):388-393. PubMed ID: 28369870
[TBL] [Abstract][Full Text] [Related]
25. Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population.
Wang CC; Chen WL; Kao TW; Chang YW; Loh CH; Chou CC
Clin Ther; 2011 Dec; 33(12):1904-13. PubMed ID: 22118894
[TBL] [Abstract][Full Text] [Related]
26. Impact of the use of anti-diabetic drugs on survival of diabetic dialysis patients: a 5-year retrospective cohort study in Taiwan.
Hsiao PJ; Wu KL; Chiu SH; Chan JS; Lin YF; Wu CZ; Wu CC; Kao S; Fang TC; Lin SH; Chen JS
Clin Exp Nephrol; 2017 Aug; 21(4):694-704. PubMed ID: 27599981
[TBL] [Abstract][Full Text] [Related]
27. Treatment with human insulin does not increase thyroid cancer risk in patients with type 2 diabetes.
Tseng CH
Eur J Clin Invest; 2014 Aug; 44(8):736-42. PubMed ID: 24931333
[TBL] [Abstract][Full Text] [Related]
28. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals.
Lee MS; Hsu CC; Wahlqvist ML; Tsai HN; Chang YH; Huang YC
BMC Cancer; 2011 Jan; 11():20. PubMed ID: 21241523
[TBL] [Abstract][Full Text] [Related]
29. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
[TBL] [Abstract][Full Text] [Related]
30. Anti-diabetic medications and risk of primary liver cancer in persons with type II diabetes.
Hagberg KW; McGlynn KA; Sahasrabuddhe VV; Jick S
Br J Cancer; 2014 Oct; 111(9):1710-7. PubMed ID: 25093492
[TBL] [Abstract][Full Text] [Related]
31. Oral hypoglycaemic agents and the development of non-fatal cardiovascular events in patients with type 2 diabetes mellitus.
Hung YC; Lin CC; Wang TY; Chang MP; Sung FC; Chen CC
Diabetes Metab Res Rev; 2013 Nov; 29(8):673-9. PubMed ID: 23956007
[TBL] [Abstract][Full Text] [Related]
32. Rosiglitazone and myocardial infarction in patients previously prescribed metformin.
Dormuth CR; Maclure M; Carney G; Schneeweiss S; Bassett K; Wright JM
PLoS One; 2009 Jun; 4(6):e6080. PubMed ID: 19562036
[TBL] [Abstract][Full Text] [Related]
33. Antidiabetic therapies affect risk of pancreatic cancer.
Li D; Yeung SC; Hassan MM; Konopleva M; Abbruzzese JL
Gastroenterology; 2009 Aug; 137(2):482-8. PubMed ID: 19375425
[TBL] [Abstract][Full Text] [Related]
34. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
Tseng CH
Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
[TBL] [Abstract][Full Text] [Related]
35. Metformin is associated with a lower risk of active tuberculosis in patients with type 2 diabetes.
Lin SY; Tu HP; Lu PL; Chen TC; Wang WH; Chong IW; Chen YH
Respirology; 2018 Nov; 23(11):1063-1073. PubMed ID: 29943489
[TBL] [Abstract][Full Text] [Related]
36. Diabetes, insulin use, and gastric cancer: a population-based analysis of the Taiwanese.
Tseng CH
J Clin Gastroenterol; 2013 Jul; 47(6):e60-4. PubMed ID: 23269314
[TBL] [Abstract][Full Text] [Related]
37. Pioglitazone does not affect the risk of kidney cancer in patients with type 2 diabetes.
Tseng CH
Metabolism; 2014 Aug; 63(8):1049-55. PubMed ID: 24889868
[TBL] [Abstract][Full Text] [Related]
38. Anti-diabetic medications and the risk for colorectal cancer: A population-based nested case-control study.
Shin CM; Kim N; Han K; Kim B; Jung JH; Oh TJ; Lee DH
Cancer Epidemiol; 2020 Feb; 64():101658. PubMed ID: 31887708
[TBL] [Abstract][Full Text] [Related]
39. Pioglitazone and thyroid cancer risk in Taiwanese patients with type 2 diabetes 2.
Tseng CH
J Diabetes; 2014 Sep; 6(5):448-50. PubMed ID: 24646421
[No Abstract] [Full Text] [Related]
40. Are sulfonylurea and insulin therapies associated with a larger risk of cancer than metformin therapy? A retrospective database analysis.
Kowall B; Rathmann W; Kostev K
Diabetes Care; 2015 Jan; 38(1):59-65. PubMed ID: 25336750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]